Magnetic resonance imaging of sinonasal malignancies

Topics in Magnetic Resonance Imaging

Volumn 18, Issue 4, 2007, Pages 259-267

  Raghavan, Prashant ^a,b   Phillips, C Douglas ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

MRI; Sinonasal tumors

Indexed keywords

ADENOCARCINOMA; CANCER INVASION; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; ESTHESIONEUROBLASTOMA; ETHMOID SINUS; HUMAN; MELANOMA; METASTASIS; NEOPLASM; NOSE CAVITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOLYSIS; PARANASAL SINUS; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; UNDIFFERENTIATED CARCINOMA;

ADENOCARCINOMA; CARCINOMA, NEUROENDOCRINE; CARCINOMA, SQUAMOUS CELL; HUMANS; MAGNETIC RESONANCE IMAGING; MELANOMA; NEOPLASM STAGING; NEUROBLASTOMA; NOSE NEOPLASMS; PARANASAL SINUS NEOPLASMS;

EID: 34748891718     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/RMR.0b013e31815711b7     Document Type: Review

References (40)

1. Muir C, Weiland L. Upper aerodigestive tract cancer. Cancer. 1995;75:147-153.
2. Sisson GA, Tariumi DM, Atiyah RA. Paranasal sinus malignancy: a comprehensive update. Laryngoscope. 1989;99:143-150.
3. Imola J, Schramm VL. Orbital preservation in surgical management of sinonasal malignancy. Laryngoscope. 2002;112:1357-1365.
4. Hermans R, De Vuysere S, Marchal G. Squamous cell carcinoma of the sinonasal cavities. Semin Ultrasound CT MR. 1999;20:150-161.
5. Som PM, Brandwein MS. Tumors and tumor-like conditions, In: Som PM, Curtin HD, eds. Head and Neck Imaging. 4th ed. St. Louis, MO: Mosby; 2003:261-373.
6. Fleming I, Cooper J, Henson D, et al. American Joint Committee on Cancer Staging Manual. 5th ed. Philadelphia, PA: Lippincott Raven; 1997.
7. Greene FL, Page DL, Fleming D, eds. American Joint Committee on Cancer Staging Manual. 5th ed. Philadelphia, PA: Lippincott Raven; 2002.
8. Yousem DM, Gad K. Tufano RP. Resectability issues with head and neck cancer. AJNR Am J Neuroradiol. 2006;27:2024-2036.
9. O'Sullivan B, Shah J. New TNM staging criteria for head and neck tumors. Semin Surg Oncol. 2003;21:30-42.
10. Loevner LA, Sonners AI. Imaging of neoplasms of the paranasal sinuses. Magn Reson Imaging Clin N Am. 2002;10:467-493.
11. Sklar EML, Pizarro JA. Sinonasal intestinal type adenocarcinoma involvement of the paranasal sinuses. AJNR Am J Neuroradiol. 2003;24:1152-1155.
12. Klintenburg C, Olofson J, Hellquist H, et al. Adenocarcinoma of the ethmoid sinuses: a review of 28 cases with special reference to wood dust exposure. Cancer. 1984;54:482-488.
13. Yousem DM, Li C, Montone KJ, et al. Primary malignant melanoma of the sinonasal cavity: MR imaging evaluation. Radiographics. 1996;16:1101-1110.
14. Chang PC, Fischbein NJ, McCalmont TH, et al. Perineural spread of malignant melanoma of the head and neck: clinical and imaging features. AJNR Am J Neuroradiol. 2004;25:5-11.
15. Patel SG, Prasad ML, Escrig M, et al. Primary mucosal malignant melanoma of the head and neck. Head Neck. 2002;24:247-257.
16. Schuster JJ, Phillips CD, Levine PA. MRI of olfactory neuroblastoma and appearance after craniofacial resection. AJNR Am J Neuroradiol. 1994;15:1169-1177.
17. Lund VL, Howard D, Wei W, et al. Olfactory neuroblastoma: past, present and future? Laryngoscope. 2003;113:502-507.
18. Eden BV, Debo RF, Larner JM, et al. Esthesioneuroblastoma, long term occurrence and patterns of failure: the University of Virginia experience. Cancer. 1994;73:2556-2562.
19. Frierson HF Jr, Mills SE, Fechner RE, et al. Sinonasal undifferentiated carcinoma derived from schneiderian epithelium and distinct from olfactory neuroblastoma. Am J Surg Pathol. 1986;10:771-779.
20. Silva E, Butler J, Mackey B, et al. Neuroblastoma and neuroendocrine carcinoma of the nasal cavity: a proposed new classification. Cancer. 1982;50:2388-2405.
21. Phillips CD, Futterer SF, Lipper MH, et al. Sinonasal undifferentiated carcinoma: CT and MR appearance of an uncommon neoplasm of the sinonasal cavity. Radiology. 1997;202:477-480.
22. Som P, Shapiro M, Biller H, et al. Sinonasal tumors and inflammatory diseases: differentiation with MR imaging. Radiology. 1988;167:803-808.
23. Mosesson RE, Som PM. The radiographic evaluation of sinonasal tumors, an overview. Otolaryngologic Clin N Am. 1995;28:1097-1115.
24. Xie CM, Xu GZ, Huang YR, et al. Spiral CT and MRI in assessment of the skull base encroachment in nasopharyngeal carcinoma (in Chinese). Ai Zheng. 2003;22:729-733.
25. Van Tuyl R, Gussock GS. Prognostic factors in craniofacial surgery. Laryngoscope. 1991;101:240-244.
26. Catalano PJ, Sen C. Management of anterior ethmoid and frontal sinus tumors. Otolaryngologic Clin N Am. 1995;28:1157-1174.
27. Eisen MD, Yousem DM, Montone KT. Use of preoperative MR to predict dural, perineural and venous sinus invasion of skull base tumors. AJNR Am J Neuroradiol. 1996;17:1937-1945.
28. Conley J. The risk to the orbit in head and neck cancer. Laryngoscope. 1985;95:515-521.
29. McCary SW, Levine PA. Management of the eye in the treatment of sinonasal cancers. Otolaryngologic Clin N Am. 1995;28:1231-1238.
30. Eisen MD, Yousem DM, Loevner LA, et al. Preoperative MR imaging to predict orbital invasion by tumor. Head Neck. 2000;22:456-462.
31. Gandour-Edwards R, Kapadia S, Barnes L, et al. Neural cell adhesion molecule in adenoid cystic carcinoma invading the skull base. Otolaryngol Head Neck Surg. 1997;117:453-458.
32. Vural E, Hutcheson J, Kourourian S, et al. Correlation of neural cell adhesion molecules with perineural spread of squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg. 2000;122:717-720.
33. Ginsberg LE. MR imaging of perineural tumor spread. Magn Reson Imaging Clin N Am. 2002;10:511-525.
34. Gandhi D, Gujar S, Mukherji SK. Magnetic resonance imaging of perineural spread of head and neck malignancies. Top Magn Reson Imaging. 2004;15:79-85.
35. van der Brekel MW, Castelijns JA, Stel HV, et al. Detection and characterization of metastatic cervical adenopathy by MR imaging: comparison of different MR techniques. J Comput Assist Tomogr. 1990;14:581-589.
36. Anzai Y. Superparamagnetic iron oxide nanoparticles: nodal metastases and beyond. Top Magn Reson Imaging. 2004;15:103-111.
37. Anzai Y, Piccol ICW, Outwater EK, et al. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MRI: phase III safety and efficacy study. Radiology. 2003;228:777-788.
38. Sumi M, Sakihama N, Sumi T, et al. Discrimination of metastatic cervical lymph nodes with diffusion weighted MRI in patients with head and neck cancer. AJNR Am J Neuroradiol. 2003;24:1627-1634.
39. Fischbein NJ, Noworolski SM, Henry RG, et al. Assessment of metastatic cervical lymphadenopathy using dynamic contrast enhanced MR imaging. AJNR Am J Neuroradiol. 2003;24:301-311.
40. Anzai Y, Carroll WR, Quint DJ. Recurrence of head and neck cancer after surgery or irradiation; prospective comparison of 2 deoxy-2-[F-18]-fluoro-D- glucose, PET and MR imaging diagnoses. Radiology. 1996;200:135-141.